Epigenetic reprogramming of cortical neurons through alteration of dopaminergic circuits

Molecular Psychiatry

Volumn 19, Issue 11, 2014, Pages 1193-1200

  Brami Cherrier, K ^a,b   Anzalone, A ^a,b   Ramos, M ^a,b   Forne, I ^c   Macciardi, F ^b   Imhof, A ^b,c   Borrelli, E ^a,b  

^a INSERM   (France)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; DOPAMINE AUTORECEPTOR; DOPAMINE RECEPTOR STIMULATING AGENT; QUINPIROLE; AUTORECEPTOR; DOPAMINE; DOPAMINE 2 RECEPTOR; HISTONE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN CELL; CHROMATIN; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC SYSTEM; DOWN REGULATION; EPIGENETICS; GENE EXPRESSION; LONG TERM CARE; MOUSE; NEUROTRANSMISSION; NONHUMAN; NUCLEAR REPROGRAMMING; PHENOTYPE; PREFRONTAL CORTEX; AGONISTS; ANIMAL; DOPAMINERGIC NERVE CELL; DRUG EFFECTS; GENETIC EPIGENESIS; GENETICS; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOTIC DISORDERS; TRANSGENIC MOUSE;

ANIMALS; AUTORECEPTORS; CORPUS STRIATUM; DOPAMINE; DOPAMINE AGONISTS; DOPAMINERGIC NEURONS; DOWN-REGULATION; EPIGENESIS, GENETIC; GENE EXPRESSION; HISTONES; MICE, TRANSGENIC; PREFRONTAL CORTEX; PSYCHOTIC DISORDERS; QUINPIROLE; RECEPTORS, DOPAMINE D2;

EID: 84908542336     PISSN: 13594184     EISSN: 14765578     Source Type: Journal    
DOI: 10.1038/mp.2014.67     Document Type: Article

References (34)

1. Jaenisch R, Bird A. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet 2003; 33(Suppl): 245-254.
2. Borrelli E, Nestler EJ, Allis CD, Sassone-Corsi P. Decoding the epigenetic language of neuronal plasticity. Neuron 2008; 60: 961-974.
3. Howes OD, Kapur S. The dopamine hypothesis of schizophrenia: version III-The final common pathway. Schizophr Bull 2009; 35: 549-562.
4. Kuepper R, Skinbjerg M, Abi-Dargham A. The dopamine dysfunction in schizophrenia revisited: new insights into topography and course. Handb Exp Pharmacol 2012; 212: 1-26.
5. Lyon GJ, Abi-Dargham A, Moore H, Lieberman JA, Javitch JA, Sulzer D. Presynaptic regulation of dopamine transmission in schizophrenia. Schizophr Bull 2011; 37: 108-117.
6. Miyake N, Thompson J, Skinbjerg M, Abi-Dargham A. Presynaptic dopamine in schizophrenia. CNS Neurosci Ther 2011; 17: 104-109.
7. Heinz A, Romero B, Gallinat J, Juckel G, Weinberger DR. Molecular brain imaging and the neurobiology and genetics of schizophrenia. Pharmacopsychiatry 2003; 36(Suppl 3): S152-S157.
8. Howes O, Bose S, Turkheimer F, Valli I, Egerton A, Stahl D, et al. Progressive increase in striatal dopamine synthesis capacity as patients develop psychosis: a PET study. Mol Psychiatry 2011; 16: 885-886.
9. Howes OD, Egerton A, Allan V, McGuire P, Stokes P, Kapur S. Mechanisms underlying psychosis and antipsychotic treatment response in schizophrenia: insights from PET and SPECT imaging. Curr Pharm Des 2009; 15: 2550-2559.
10. Bertolino A, Knable MB, Saunders RC, Callicott JH, Kolachana B, Mattay VS, et al. The relationship between dorsolateral prefrontal N-acetylaspartate measures and striatal dopamine activity in schizophrenia. Biol Psychiatry 1999; 45: 660-667.
11. Meyer-Lindenberg A, Miletich RS, Kohn PD, Esposito G, Carson RE, Quarantelli M, et al. Reduced prefrontal activity predicts exaggerated striatal dopaminergic function in schizophrenia. Nat Neurosci 2002; 5: 267-271.
12. Rice ME, Patel JC, Cragg SJ. Dopamine release in the basal ganglia. Neuroscience 2011; 198: 112-137.
13. Rouge-Pont F, Usiello A, Benoit-Marand M, Gonon F, Piazza PV, Borrelli E. Changes in extracellular dopamine induced by morphine and cocaine: crucial control by D2 receptors. J Neurosci 2002; 22: 3293-3301.
14. Benoit-Marand M, Borrelli E, Gonon F. Inhibition of dopamine release via presynaptic D2 receptors: time course and functional characteristics in vivo. J Neurosci 2001; 21: 9134-9141.
15. Anzalone A, Lizardi-Ortiz JE, Ramos M, De Mei C, Hopf FW, Iaccarino C, et al. Dual control of dopamine synthesis and release by presynaptic and postsynaptic dopamine D2 receptors. J Neurosci 2012; 32: 9023-9034.
16. Jasencakova Z, Scharf AN, Ask K, Corpet A, Imhof A, Almouzni G, et al. Replication stress interferes with histone recycling and predeposition marking of new histones. Mol Cell 2010; 37: 736-743.
17. Kumar A, Choi KH, Renthal W, Tsankova NM, Theobald DE, Truong HT, et al. Chromatin remodeling is a key mechanism underlying cocaine-induced plasticity in striatum. Neuron 2005; 48: 303-314.
18. Paylor R, Crawley JN. Inbred strain differences in prepulse inhibition of the mouse startle response. Psychopharmacology 1997; 132: 169-180.
19. Errico F, Rossi S, Napolitano F, Catuogno V, Topo E, Fisone G, et al. D-aspartate prevents corticostriatal long-Term depression and attenuates schizophrenia-like symptoms induced by amphetamine and MK-801. J Neurosci 2008; 28: 10404-10414.
20. Wood MA, Kaplan MP, Brensinger CM, Guo W, Abel T. Ubiquitin C-Terminal hydrolase L3 (Uchl3) is involved in working memory. Hippocampus 2005; 15: 610-621.
21. Maze I, Noh KM, Allis CD. Histone regulation in the CNS: basic principles of epigenetic plasticity. Neuropsychopharmacology 2013; 38: 3-22.
22. Akbarian S, Huang HS. Epigenetic regulation in human brain-focus on histone lysine methylation. Biol Psychiatry 2009; 65: 198-203.
23. Russo SJ, Nestler EJ. The brain reward circuitry in mood disorders. Nat Rev Neurosci 2013; 14: 609-625.
24. Barski A, Cuddapah S, Cui K, Roh TY, Schones DE, Wang Z, et al. High-resolution profiling of histone methylations in the human genome. Cell 2007; 129: 823-837.
25. Fodor BD, Kubicek S, Yonezawa M, O'Sullivan RJ, Sengupta R, Perez-Burgos L, et al. Jmjd2b antagonizes H3K9 trimethylation at pericentric heterochromatin in mammalian cells. Genes Dev 2006; 20: 1557-1562.
26. Rojas P, Joodmardi E, Hong Y, Perlmann T, Ogren SO. Adult mice with reduced Nurr1 expression: an animal model for schizophrenia. Mol Psychiatry 2007; 12: 756-766.
27. Emamian ES, Hall D, Birnbaum MJ, Karayiorgou M, Gogos JA. Convergent evidence for impaired AKT1-GSK3beta signaling in schizophrenia. Nat Genet 2004; 36: 131-137.
28. Arguello PA, Gogos JA. Modeling madness in mice: one piece at a time. Neuron 2006; 52: 179-196.
29. Jones CA, Watson DJ, Fone KC. Animal models of schizophrenia. Br J Pharmacol 2011; 164: 1162-1194.
30. Seeman P. All roads to schizophrenia lead to dopamine supersensitivity and elevated dopamine D2(high) receptors. CNS Neurosci Ther 2011; 17: 118-132.
31. Yoon T, Okada J, Jung MW, Kim JJ. Prefrontal cortex and hippocampus subserve different components of working memory in rats. Learn Mem 2008; 15: 97-105.
32. Papaleo F, Yang F, Garcia S, Chen J, Lu B, Crawley JN, et al. Dysbindin-1 modulates prefrontal cortical activity and schizophrenia-like behaviors via dopamine/D2 pathways. Mol Psychiatry 2012; 17: 85-98.
33. Goto Y, Grace AA. The dopamine system and the pathophysiology of schizophrenia: a basic science perspective. Int Rev Neurobiol 2007; 78: 41-68.
34. Whetstine JR, Nottke A, Lan F, Huarte M, Smolikov S, Chen Z, et al. Reversal of histone lysine trimethylation by the JMJD2 family of histone demethylases. Cell 2006; 125: 467-481.